291. Hirschsprung disease, entire colon type
[
10 clinical trials,
20 drugs（DrugBank:
12 drugs),
0 target gene / 0 target pathway ]
Searched query = "Hirschsprung disease, entire colon type", "Hirschsprung disease, small intestine type", "Hirschsprung disease", "Hirschprung disease", "Hirschsprung disease associated entercolitis"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04020939 | September 1, 2019 | 29 July 2019 | The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. | The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery. | Intestinal Atresia;Necrotizing Enterocolitis;Hirschsprung Disease;Gastroschisis;Intestinal Obstruction;Incarcerated Hernia;Intussusception;Malrotation;Volvulus;Meconium Ileus;Intestinal Perforation;Trauma | Device: SPY imaging;Drug: Indocyanine Green | St. Justine's Hospital | Not recruiting | N/A | 16 Years | All | 35 | N/A | ||
| 2 | NCT03660176 | January 2, 2019 | 17 September 2018 | Effects of Butyrate Enemas on Postoperative Intestinal Mobility Disorders in Hirschsprung's Disease | Effects of Butyrate Enemas on Postoperative Intestinal Mobility Disorders in Hirschsprung's | Hirschsprung's Disease | Drug: butyrate enemas + routine management;Other: routine management | Assistance Publique Hopitaux De Marseille | Not recruiting | N/A | 17 Years | All | 58 | Phase 3 | France | |
| 3 | NCT03593252 | September 1, 2018 | 23 July 2018 | Bowel Preparation in Elective Pediatric Intestinal Surgery | Mechanical Bowel Prep and Prophylactic Oral Antibiotic Use in Children: Implications for Intestinal Surgery Complications | Colostomy Stoma;Ileostomy - Stoma;Jejunostomy Stoma;Hirschprung's Disease;NEC;Inflammatory Bowel Diseases;Meconium Ileus;Bowel Obstruction | Drug: Senna;Drug: Sodium Picosulfate, Magnesium Oxide and Citric Acid;Drug: Erythromycin;Drug: Kanamycin;Drug: Cefazolin;Drug: Metronidazole;Other: Nil per os | McMaster University | Not recruiting | 6 Months | 18 Years | All | 48 | N/A | ||
| 4 | NCT02343562 | October 2014 | 5 February 2018 | Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis | Probiotics for Prophylaxis of Postoperative Hirschsprungs Associated Enterocolitis | Hirschsprung Disease | Dietary Supplement: Probiotics;Dietary Supplement: Placebo | Cairo University | Recruiting | 6 Months | 12 Years | All | 40 | Phase 4 | Egypt | |
| 5 | NCT02234219 | January 2014 | 30 September 2019 | Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease: A Prospective Multicenter Randomized Controlled Trial | Comparison of Circular(Soave) and Heart-shaped Anastomosis in Hirschsprung's Disease: A Prospective Multicenter Randomized Controlled Trial | Constipation | Drug: Probiotics | Tongji Hospital | Recruiting | N/A | 14 Years | All | 50 | N/A | China | |
| No. | TrialID | Date_ enrollement | Last_Refreshed_ on | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
| 6 | NCT02350088 | January 2014 | 19 February 2015 | Fast-track Surgery in the Treatment of Hirschsprung's Disease | Fast-track Surgery in the Treatment of Hirschsprung's Disease | Surgery | Drug: probiotics;Drug: placebo | Tongji Hospital | Children's Hospital Boston | Recruiting | 1 Year | 18 Years | Both | 100 | N/A | China |
| 7 | NCT02216994 | January 2013 | 19 February 2015 | A New Scoring System Improves Diagnostic Accuracy of Intestinal Dysganglionosis --a Prospective Study | Efficacy and Accuracy of a New Diagnostic Scoring System to Differentiate Hirschsprung Disease From Hirschsprung Disease Allied Disorders in the Patients With Suspected Intestinal Dysganglinosis: a Prospective Study | Hirschsprung Disease | Drug: high dose lactulose;Behavioral: conservative treatment;Drug: paraffin oil | Tongji Hospital | Jiangxi Provincial Children's Hospital | Recruiting | N/A | 3 Years | Both | 80 | N/A | China |
| 8 | NCT01985646 | October 2009 | 19 February 2015 | A Trial on Conservative Treatment for Infants' Hirschsprung Disease | A Prospective, Randomized Controlled Trial of Conservative Versus Surgery Treatment of Normal and Short-segment Hirschsprung Disease for Infants | Hirschsprung Disease | Procedure: surgery treatment;Behavioral: anal dilation;Behavioral: colonic lavage;Drug: oral probiotic | Tongji Hospital | Not recruiting | N/A | 3 Months | Both | 48 | Phase 0 | ||
| 9 | NCT01934959 | January 2008 | 19 February 2015 | A Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis | A Prospective Multicenter Randomized Controlled Trial on Probiotics in Preventing Hirschsprung's Disease Associated Entercolitis | Probiotics;Hirschsprung's Disease Associated Enterocolitis | Drug: Bifico | Tongji Hospital | Anhui Provincial Hospital | Not recruiting | 1 Month | 13 Years | Both | 60 | Phase 0 | |
| 10 | NCT00630838 | September 2006 | 19 October 2017 | Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC) | Probiotic Prophylaxis of Hirschprung's Disease Associated Enterocolitis (HAEC) | Hirschsprung Disease | Drug: VSL#3;Drug: Placebo | University of Michigan | Not recruiting | 1 Month | 12 Months | All | 62 | Phase 2 | United States |